Zacks Research Issues Positive Marks for Advaxis (ADXS) Phase II Study for ADXS-HPV
Analysts call results “very encouraging” (06/07/2013 10:00 AM)
Rainbow BioSciences (RBCC) Continues Potential Partner Talks with Transdermal Patch Company
Company looks to partake in the $142 billion drug delivery market (06/06/2013 13:00 PM)
International Stem Cell Corp. (ISCO) Initiates Final Step to File IND for Treatment of Parkinson’s Disease
International Stem Cell Corp. (ISCO) Initiates Final Step to File IND for Treatment of Parkinson’s Disease (05/31/2013 10:00 AM)
VentriPoint Diagnostics (VPTDF) Technology Now Used by Hospitals around the World
Technology offers a radically new and more cost effective way of performing critical heart imagery (05/29/2013 10:00 AM)
Advaxis (ADXS) Makes Two New Appointments
Dr. Robert Petit and Daniel J. O’Connor move to new roles in the company (05/14/2013 10:00 AM)
VistaGen Therapeutics (VSTA) and Duke University Report Positive Results on Production of Functional 3D Human Heart Tissue
“Heart patch” contracts at speed similar to the natural functions of human heart tissue (05/08/2013 10:00 AM)
Cardium Therapeutics (CXM) to Showcase Excellagen® in Poster Presentation at the 2013 Spring SAWC/WHS Meeting
Presentation to demonstrat the clinical benefits of its lead commercial product, Excellagen® (05/01/2013 10:00 AM)
Dr. Garber's Natural Solutions Signs Distribution Deal with Amazon.com
Dr. Garber's Natural Solutions® is pleased to announce that their condition specific biotherapy formulas are now sold directly through Amazon.com. (04/29/2013 08:12 AM)
QualityStocks News - Advaxis Represents the New War Against Cancer And Infectious Disease
Company’s immunotherapies attack disease in a more precision manner (04/12/2013 10:00 AM)
MissionIR News - VistaGen Therapeutics Secures $36 Million to Accelerate Drug Rescue, Predictive Toxicology, and Drug Metabolism Programs
Company signs financing agreement with the European subsidiary of Bergamo Acquisition (04/11/2013 10:00 AM)
